Group One Trading
IGMS

Group One Trading’s IGM Biosciences IGMS Stock Holding History

Group One Trading’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,100
Closed -$67.8K – 7582
2024
Q3 		$67.8K Buy
+4,100
New +$44.9K ﹤0.01% 4445
2024
Q1 		– Sell
-4,900
Closed -$40.7K – 7450
2023
Q4 		$40.7K Buy
4,900
+1,400
+40% +$8.13K ﹤0.01% 5224
2023
Q3 		$29.2K Buy
3,500
+1,100
+46% +$9.33K ﹤0.01% 5567
2023
Q2 		$22.2K Buy
+2,400
New +$26.9K ﹤0.01% 5928
2023
Q1 		– Sell
-700
Closed -$11.9K – 7522
2022
Q4 		$11.9K Sell
700
-300
-30% -$6K ﹤0.01% 5937
2022
Q3 		$23K Buy
1,000
+300
+43% +$6.06K ﹤0.01% 5971
2022
Q2 		$13K Sell
700
-81,600
-99% -$1.45M ﹤0.01% 6608
2022
Q1 		$2.2M Buy
82,300
+80,100
+3,641% +$1.49M ﹤0.01% 2310
2021
Q4 		$65K Sell
2,200
-2,600
-54% -$129K ﹤0.01% 6110
2021
Q3 		$316K Buy
4,800
+4,600
+2,300% +$352K ﹤0.01% 4693
2021
Q2 		$17K Buy
200
+100
+100% +$7.41K ﹤0.01% 7285
2021
Q1 		$8K Hold
100
– – ﹤0.01% 7115
2020
Q4 		$9K Buy
+100
New +$7.03K ﹤0.01% 5823

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading's IGMS Position: Q3 2024 in Review

Group One Trading sold out of IGM Biosciences (IGMS) in Q3 2024, closing a stake of 304 shares — an estimated $3.33K sold.

Group One Trading first reported a position in IGMS in Q3 2021 and held it in 7 quarters. The position peaked at $458K in Q3 2021. 72 funds tracked by Wall St. Rank hold IGMS as of Q3 2024.

  • Group One Trading reported no remaining IGM Biosciences position as of Q3 2024 after selling out during the quarter.
  • Group One Trading sold 304 IGM Biosciences shares in Q3 2024, an estimated $3.33K.
  • Group One Trading first reported a position in IGM Biosciences in Q3 2021 and held it in 7 quarters.
  • Group One Trading's IGM Biosciences position peaked at $458K in Q3 2021.
  • 72 funds tracked by Wall St. Rank held IGM Biosciences as of Q3 2024.

Based on Group One Trading's 13F filing for Q3 2024, filed 14 Nov 2024.